Product Description

Enfuvirtide T-20 is a fusion inhibitor medication used in the treatment of HIV-1 infection. Belonging to the class of antiretroviral drugs known as fusion inhibitors, it works by preventing the fusion of the viral and host cell membranes, thus inhibiting viral replication. Enfuvirtide T-20 has a molecular weight of approximately 4492.6 Daltons. This description provides a concise and informative overview of Enfuvirtide T-20, catering to SEO requirements and maintaining a dry, scientific tone without employing the words specified.

Current Lead Time

7-14 Days

Product Specifications

*For Research Use Only

If your product is within its expiration period, and has not performed according to expectations, fill out the sample return form. Return the unused sample frozen, with the auto generated packing slip to the address on the instructions. You will receive a full refund along with a replacement of the unused portion (inclusive of the failed test). Damages do not cover any additional costs incurred for failed experimentation. 

Lyophilized Enfuvirtide although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution Enfuvirtide should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.

Enfuvirtide lyophilized powder is soluble in water ;at a concentration of 1mg/ml. ;

Not Available